World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
25649
World Ranking
11894
National Ranking
377

John O. Miners publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John O. Miners sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 320 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John O. Miners D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John O. Miners sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John O. Miners is affiliated with Flinders University in Australia. Their research primarily spans the fields of Medicine, Pharmacology, Toxicology and Pharmaceutics, and Biochemistry, Genetics and Molecular Biology. Within these areas, their subfields of study include Pharmacology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, and Pediatrics, Perinatology and Child Health.

The scientist's work focuses on topics such as Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Neonatal Health and Biochemistry, Neurotransmitter Receptor Influence on Behavior, Drug-Induced Hepatotoxicity and Protection, Cancer Immunotherapy and Biomarkers, and Colorectal Cancer Treatments and Studies.

Among recent publications are these:

  • Binding of clozapine to the GABAB receptor: clinical and structural insights, 2020, Molecular Psychiatry
  • Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease, 2022, JAMA
  • Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping, 2020, Pharmacology & Therapeutics
  • Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab, 2020, Journal of the National Comprehensive Cancer Network
  • Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance, 2023, Pharmacology & Therapeutics

The most frequent co-authors in their body of work include Andrew Rowland, Pramod C. Nair, Ashley M. Hopkins, Michael J. Sorich, and Ross A. McKinnon.

John O. Miners has published repeatedly in several key venues such as Molecular Psychiatry, Pharmacology & Therapeutics, Journal of the National Comprehensive Cancer Network, Drug Metabolism and Pharmacokinetics, and Clinical Pharmacology & Therapeutics.

Best Publications

  • Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

    John O. Miners;Donald J. Birkett

  • Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.

    Peter I Mackenzie;Karl Walter Bock;Brian Burchell;Chantal Guillemette

  • The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.

    Theresa H. Sullivan-Klose;Burhan I. Ghanayem;Douglas A. Bell;Zhi Yi Zhang

  • The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.

    Andrew Rowland;John Oliver Miners;Peter Ian Mackenzie

  • HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID

    Verawan Uchaipichat;Peter I. Mackenzie;Xiao-Hui Guo;Xiao-Hui Guo;Dione Gardner-Stephen

  • Drug glucuronidation in humans.

    John O. Miners;Peter I. Mackenzie

  • Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

    W Tassaneeyakul;D J Birkett;M E Veronese;M E McManus

  • SELECTIVITY OF SUBSTRATE (TRIFLUOPERAZINE) AND INHIBITOR (AMITRIPTYLINE, ANDROSTERONE, CANRENOIC ACID, HECOGENIN, PHENYLBUTAZONE, QUINIDINE, QUININE, AND SULFINPYRAZONE) “PROBES” FOR HUMAN UDP-GLUCURONOSYLTRANSFERASES

    Verawan Nu Uchaipichat;Peter Ian Mackenzie;David John Elliot;John Oliver Miners

  • The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation

    Roger Drew;John O. Miners

  • The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.

    John Oliver Miners;Peter Ian Mackenzie;Kathleen Mary Knights

  • Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.

    C. Bhasker;Wendy McKinnon;Andrew Stone;Angus Lo;Angus Lo

  • Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.

    Michael H. Court;Su X. Duan;Lisa L. von Moltke;David J. Greenblatt

  • Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

    Tommy Andersson;Tommy Andersson;John O. Miners;Maurice E. Veronese;Wichittra Tassaneeyakul

  • Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.

    Chunjing Jin;J. O. Miners;K. J. Lillywhite;P. I. Mackenzie

  • Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance

    John O Miners;Ross A McKinnon;Peter I Mackenzie

  • In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.

    John Oliver Miners;Kathleen Mary Knights;J Brian Houston;Peter Ian Mackenzie

  • Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9.

    Maurice E. Veronese;Peter I. Mackenzie;Christopher J. Doecke;Michael E. McManus

  • Diazepam metabolism by human liver microsomes is mediated by both S‐ mephenytoin hydroxylase and CYP3A isoforms.

    T Andersson;JO Miners;ME Veronese;DJ Birkett

  • Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms

    Wichittra Tassaneeyakul;Donald J. Birkett;Michael E. McManus;Wongwiwat Tassaneeyakul

  • In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction

    Andrew Rowland;David John Elliot;Andrew Williams;Peter Ian Mackenzie

Frequent Co-Authors

Peter I. Mackenzie
Peter I. Mackenzie Flinders University
Paul A. Smith
Paul A. Smith Australian Wine Research Institute
Joseph G. Shapter
Joseph G. Shapter University of Queensland
Richard O. Day
Richard O. Day University of New South Wales
Andrew A. Somogyi
Andrew A. Somogyi University of Adelaide
J. Brian Houston
J. Brian Houston University of Manchester
Robert H. Tukey
Robert H. Tukey University of California, San Diego
Peter Brooks
Peter Brooks University of Melbourne
David A. Winkler
David A. Winkler La Trobe University
Nicolas H. Voelcker
Nicolas H. Voelcker Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a medical career in the USA, exploring allied online degrees can open up a range of opportunities. Many professionals pursue healthcare administration, nursing, or advanced practice degrees to diversify their skills and advance faster in the healthcare field.

For those interested in the business and management side of healthcare, it is vital to consider which online healthcare administration programs have CAHME accreditation. This accreditation ensures the quality and industry recognition of your degree. Nurses looking to further their careers may want to explore RN to BSN programs, which provide flexible, non-clinical pathways to earning a bachelor’s in nursing.

Advanced nursing degrees, such as the Doctor of Nursing Practice (DNP), are increasingly popular for career progression. You can learn about the shortest post master's DNP program options if you already hold a master’s degree and want to complete your studies efficiently. Cost is also a major factor, so many students seek out the cheapest online DNP programs to balance quality education with affordability.

These pathways enable aspiring healthcare professionals to adapt to changing industry demands while offering the flexibility of online learning.

Best Scientists Citing John O. Miners

Trending Scientists